Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Is TB-500 a Growth Hormone? The Real Answer for Researchers

It’s a question our team hears all the time, and honestly, we get why. In the sprawling world of peptide research, terminology can get tangled, and compounds with seemingly similar outcomes get lumped together. You see chatter about recovery, regeneration, and

It’s a question our team hears all the time, and honestly, we get why. In the sprawling world of peptide research, terminology can get tangled, and compounds with seemingly similar outcomes get lumped together. You see chatter about recovery, regeneration, and tissue repair, and it’s natural to connect those dots straight to the most famous growth promoter of all: human growth hormone.

But here’s the unvarnished truth, the kind of clarity we pride ourselves on at Real Peptides: the answer to is TB-500 a growth hormone is a definitive no. They aren’t just different; they operate in fundamentally separate biological universes. Thinking of them as interchangeable is like comparing a specialized surgical tool to a general contractor’s hammer. Both are used for building and repair, sure, but their application, mechanism, and precision are worlds apart. Understanding this distinction is absolutely critical for designing meaningful, accurate, and repeatable research.

Let's Clear the Air: TB-500 is Not a Growth Hormone

Let’s get this out of the way immediately. TB-500 is not a hormone of any kind. It doesn't stimulate the pituitary gland, it doesn't trigger the release of other hormones, and it doesn't function through the endocrine system's complex signaling pathways. It's a completely different class of molecule with a completely different job.

Its proper name is Thymosin Beta-4, and TB-500 is the synthetic peptide fragment that corresponds to the most active region of this naturally occurring protein. Its primary role revolves around a protein called actin. We'll dive much deeper into this shortly, but for now, think of actin as the fundamental building block for the cytoskeleton of every cell—the scaffolding that gives cells their shape and allows them to move. TB-500's magic, so to speak, lies in its ability to regulate actin. It encourages the formation of new cellular structures and facilitates cell migration.

Growth hormone (GH), on the other hand, is the real deal—a quintessential hormone. It's a massive protein-based peptide hormone secreted by the pituitary gland that stimulates growth, cell reproduction, and regeneration. It works by signaling cells throughout the body, most notably by stimulating the liver to produce another powerful growth factor called IGF-1. Its effects are systemic, broad, and deeply tied to metabolism, body composition, and overall development. It’s a top-down commander.

TB-500 is a boots-on-the-ground specialist.

So, What Exactly is TB-500? A Deeper Look

To truly appreciate the difference, we need to get a bit more granular. Thymosin Beta-4 (Tβ4) is a protein found in virtually all human and animal cells. It’s particularly concentrated in wound fluid and certain types of stem cells, which gives us a huge clue about its function. When tissue is damaged, Tβ4 levels spike in that area. It’s the body's own rapid-response team for repair.

The synthetic version researchers use, TB 500 Thymosin Beta 4, is a shorter, more manageable chain of amino acids that captures the essence of Tβ4's bioactivity. Its primary mechanism, as we touched on, is actin upregulation. But what does that actually mean for a cell?

Imagine a city after an earthquake. Roads are broken, buildings have collapsed, and communication lines are down. You need crews on site immediately to clear debris, lay new pavement, and rebuild structures. In this analogy, TB-500 is the foreman directing the construction crews (the actin). It binds to actin monomers (G-actin) and helps them link together to form filaments (F-actin). This process, called actin polymerization, is the non-negotiable first step in:

Cell Migration: Cells need to literally crawl to the site of an injury to begin repairs. This movement is driven by the rapid assembly and disassembly of the actin cytoskeleton. TB-500 helps orchestrate this migration of endothelial cells (which form blood vessels) and keratinocytes (which form skin), among others.

Angiogenesis: The formation of new blood vessels. You can't heal tissue without a blood supply to deliver oxygen and nutrients. TB-500 has been shown in various studies to promote this vital process.

Reducing Inflammation: It has a powerful anti-inflammatory effect by downregulating specific inflammatory cytokines. This creates a more favorable environment for healing to occur, reducing excessive scarring and promoting functional tissue recovery.

Our experience in synthesizing peptides has shown us that the precision of the amino acid sequence in a compound like TB-500 is everything. Even a single incorrect link in the chain can render the peptide inert or, worse, unpredictable. That’s why our small-batch synthesis process is so rigorous—it ensures that the peptide you're studying is exactly what it's supposed to be, delivering reliable and repeatable data.

Understanding Human Growth Hormone (HGH): The Master Regulator

Now, let's pivot to Human Growth Hormone. If TB-500 is a specialized repair crew, HGH is the federal agency overseeing a nationwide infrastructure project. It's a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.

Its release isn't constant; it's pulsatile, meaning it comes in bursts, primarily during deep sleep. This release is controlled by other hormones from the hypothalamus, like Growth Hormone-Releasing Hormone (GHRH) and Somatostatin.

Once in the bloodstream, HGH exerts its effects in two ways:

Direct Effects: It binds to its receptors on target cells. For example, on fat cells (adipocytes), it can trigger the breakdown of triglycerides and suppress their ability to take up and accumulate circulating lipids. Hello, fat loss.

Indirect Effects: This is its main pathway for anabolic (growth) effects. HGH travels to the liver and other tissues and stimulates the production of Insulin-like Growth Factor 1 (IGF-1). IGF-1 is the primary mediator of HGH's growth-promoting effects. It's IGF-1 that is largely responsible for the muscle growth (hypertrophy and hyperplasia) and bone development associated with GH.

This hormonal cascade is a world away from TB-500’s direct interaction with intracellular actin. HGH is about systemic growth signaling. It tells the entire body to enter a state of growth and repair. It influences metabolism, protein synthesis, and cell division on a global scale. Peptides studied for their GHRH-like effects, such as those in our Tesamorelin Ipamorelin Growth Hormone Stack, are designed to interact with this specific pituitary pathway, offering a more targeted approach to stimulating natural GH release for research purposes.

The Side-by-Side Breakdown: TB-500 vs. HGH

Sometimes, the clearest way to see the difference is to put things side-by-side. Our team put together this table to distill the key distinctions for researchers who need to make informed decisions about which compounds are appropriate for their studies.

Classification

A synthetic fragment of a naturally occurring protein.

A peptide hormone.

Primary Mechanism

Binds to and regulates actin; promotes cell migration.

Binds to GH receptors; stimulates IGF-1 production in the liver.

Main Function

Tissue repair, angiogenesis, anti-inflammatory effects.

Systemic growth, cell reproduction, metabolism regulation.

Source/Origin

Found in nearly all cells, concentrated at injury sites.

Secreted by the anterior pituitary gland in the brain.

Effect Profile

More targeted towards healing and recovery of specific tissues.

Broad, systemic anabolic and metabolic effects.

Hormonal Impact

Does not directly interact with the endocrine system.

A core component of the endocrine system; influences many hormones.

Research Focus

Wound healing, cardiac repair, soft tissue injury studies.

Anti-aging, body composition, muscle wasting, growth disorders.

This isn't to say one is better than the other. That's not the point. They are different tools for different scientific questions. You wouldn't use a screwdriver to drive a nail. Similarly, you wouldn't design a study on localized tendon repair using a systemic growth promoter as your primary variable, nor would you study a metabolic disorder using only an actin-regulating peptide.

Why Does This Confusion Even Exist?

Let's be honest, the confusion is understandable. Both compounds are peptides. Both are often administered via injection in research settings. And most importantly, both are associated with healing and recovery. This creates a significant overlap in the language used to describe their potential, even if the underlying biology is completely different.

When someone talks about recovering from a nagging injury, their description might sound similar whether they're discussing anecdotal experiences with HGH or TB-500. They might talk about reduced pain, faster return to function, and a feeling of resilience. The end result feels similar, which leads to the assumption that the cause must be similar, too.

Furthermore, the world of performance and athletics has created a narrative where anything that aids recovery is thrown into the same bucket. This is a dangerous oversimplification. HGH's recovery benefits are largely a downstream effect of its powerful systemic anabolic state—it puts the entire body into 'build mode'. TB-500's benefits are far more direct and localized to the mechanics of tissue reconstruction. It's less about building bigger and more about healing better and faster. This nuanced distinction is often lost in online forums and gym talk, but for a researcher, it is the entire ballgame.

The Real Peptides Difference: Purity in Research Matters

This brings us to a point we can't stress enough. When you're dealing with compounds that have such specific and powerful biological mechanisms, the purity and accuracy of what's in your vial is not just important—it's everything. A study's results are only as good as the materials used.

Imagine you're researching the effects of TB-500 on cardiac cell migration. If the peptide you're using is contaminated with solvent residue, or worse, has an incorrect amino acid sequence, your results will be meaningless. You might see no effect, or you might see an effect caused by the contaminant, leading you to a completely false conclusion. This is catastrophic for scientific integrity.

At Real Peptides, our entire operation is built to prevent this. We don't mass-produce. We use a meticulous small-batch synthesis process that allows for incredible quality control. Every batch is verified for its exact amino-acid sequence and purity. This ensures that when you're studying a compound like BPC 157 Peptide or TB-500, you can be confident that the effects you observe are attributable to that peptide and that peptide alone. It’s the foundation of reproducible science, and it’s a non-negotiable part of our promise to the research community.

Exploring Synergies: Combining Peptides in Research

Now, this is where it gets interesting for advanced research design. Just because TB-500 and HGH are different doesn't mean their pathways are mutually exclusive. In biology, everything is connected. This has led many researchers to investigate the synergistic potential of using different classes of peptides together.

For instance, a common research model involves pairing TB-500 with BPC-157. While TB-500 promotes actin-mediated cell migration and angiogenesis systemically, BPC-157 is thought to have a more localized effect on growth factor receptors at the site of injury. The hypothesis is that they may offer a powerful one-two punch for recovery—one working on a systemic cellular machinery level and the other on a localized signaling level. Our Wolverine Peptide Stack is designed for researchers exploring exactly this type of synergistic relationship.

Similarly, one could design a study looking at how a baseline of elevated GH/IGF-1 (stimulated by a GHRH/GHRP like Ipamorelin) might affect the healing rate promoted by TB-500. Does a globally anabolic environment enhance the efficiency of the localized, actin-driven repair mechanism? These are the kinds of complex, cutting-edge questions that drive science forward. Answering them requires a deep understanding of each compound's unique role and access to a full suite of high-purity tools, which you can find by exploring our collection of All Peptides.

The Regulatory and Research Landscape

It's crucial to state this plainly: TB-500, HGH, and the other peptides mentioned here are not approved for human consumption. They are research chemicals, intended for in-vitro and laboratory research purposes only. Their sale is for scientific inquiry into their mechanisms, potential applications, and safety profiles.

Navigating this landscape requires a partnership with a supplier who is not only compliant but also transparent. Sourcing from reputable, domestic suppliers like Real Peptides ensures you are operating within the proper framework and receiving materials that meet stringent quality standards. This protects the integrity of your research and contributes to the legitimate advancement of biochemical knowledge. It's a responsibility we take very seriously.

So, while the initial question—is TB-500 a growth hormone—is simple, the answer unlocks a much richer and more fascinating conversation. It forces us to look beyond surface-level outcomes and appreciate the elegant, specific, and distinct machinery at work inside our cells. They are two profoundly different compounds, each offering a unique window into the body's remarkable capacity for growth and repair. Understanding that difference is the first step toward conducting powerful, insightful research. We're here to provide the tools you need to take the next steps. Get Started Today.

Frequently Asked Questions

No, TB-500 is not a steroid. It is a synthetic peptide fragment of the protein Thymosin Beta-4. Steroids are a class of organic compounds with a specific four-ring carbon structure, whereas peptides are short chains of amino acids.

While both are studied for healing, their proposed mechanisms differ. TB-500 is thought to work systemically by upregulating actin to promote cell migration and angiogenesis. BPC-157 is believed to exert its effects more locally at the injury site, possibly by interacting with growth factor signaling.

Yes, like most research peptides, TB-500 is supplied as a lyophilized (freeze-dried) powder. For laboratory use, it must be reconstituted with a sterile solvent, such as [Bacteriostatic Water](https://www.realpeptides.co/products/bacteriostatic-water/), to create a stable solution for experiments.

TB-500 is a synthetic peptide that represents the active fragment of the much larger, naturally occurring protein called Thymosin Beta-4. The names are often used interchangeably in research circles to refer to this active peptide sequence.

In advanced research models, scientists may investigate the potential synergistic effects of different peptide classes. A protocol could be designed to see if an elevated GH/IGF-1 environment, stimulated by a secretagogue like Sermorelin, alters the cellular repair mechanisms influenced by TB-500.

Actin is a crucial protein that forms the cytoskeleton, or internal scaffolding, of cells. TB-500’s primary proposed mechanism is binding to and regulating actin, which is essential for cell movement, division, and structural integrity—all key processes in tissue repair.

Yes, human growth hormone is technically a large peptide hormone, composed of a chain of 191 amino acids. However, its function as a systemic hormone that triggers the release of other factors (like IGF-1) places it in a different functional class than smaller, more direct-acting peptides like TB-500.

Thymosin Beta-4 is a ubiquitous protein found in nearly all human and animal cells. Its concentration is especially high in wound fluid, platelets, and other areas associated with injury and repair, highlighting its role as a natural healing agent.

Purity is paramount because contaminants or incorrect sequences can invalidate research results. At Real Peptides, we guarantee purity through rigorous testing to ensure that any observed biological effects are due to the peptide being studied, not an unknown variable.

No, there is no evidence to suggest that TB-500 interacts with or affects the pituitary gland. Its mechanism is focused on intracellular actin regulation, completely separate from the hormonal axes controlled by the pituitary.

TB-500 is primarily studied for its potential in wound healing, soft tissue repair (muscle, tendon, ligament), cardiac repair after injury, and reducing inflammation. Its ability to promote cell migration and new blood vessel formation makes it a subject of great interest in regenerative medicine research.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

TB-500 Dosing Protocols for Scar Tissue Remodeling

The standard TB-500 protocol for scar healing follows a loading phase of 2–2.5mg administered subcutaneously twice weekly for 4–6 weeks, followed by a maintenance phase of 2mg once weekly for an additional 4–8 weeks. This dosing framework originates from veterinary tendon-repair studies in horses and has been adapted for human soft-tissue injuries in clinical practice. The twice-weekly loading dose is designed to maintain therapeutic plasma concentrations throughout the wound's proliferative phase, which peaks between days 4–21 post-injury. Dosage timing relative to injury matters more than most protocols acknowledge. TB-500 administered within 48–72 hours of injury. During the inflammatory phase. Shows the greatest impact on reducing hypertrophic scarring. A 2023 case series published in the Journal of Cosmetic Dermatology evaluated 18 patients who used TB-500 post-surgically; those who began administration within 3 days of surgery showed 41% less scar elevation at 12 weeks compared to those who started 7+ days post-op. If the wound has already transitioned into the remodeling phase (typically after 3–4 weeks), TB-500's effect on collagen organization is significantly diminished. Reconstitution sterility is the failure point that turns effective TB-500 into a contamination risk. Lyophilized TB-500 must be reconstituted with bacteriostatic water (0.9% benzyl alcohol) using aseptic technique. Wipe the vial stopper with 70% isopropyl alcohol, inject air into the vial equal to …
STORAGE

Degraded Peptides: Storage and Temperature Failures

Storage discipline separates functional TB-500 from expensive saline. The peptide is a 43-amino-acid chain. Temperature excursions above 8°C after reconstitution cause irreversible protein unfolding. You can't reverse this. The amino acid sequence doesn't revert to its bioactive form when you put the vial back in the fridge. Most degradation happens during shipping, not at home. If your TB-500 vial arrived warm to the touch, the peptide may already be compromised before you open the package. Lyophilised powder can tolerate brief ambient exposure (24–48 hours at 20–25°C), but pre-reconstituted solutions cannot. Some suppliers ship reconstituted peptides with ice packs. If the ice pack is fully melted on arrival, the shipment spent hours above safe temperature. Our experience working with research labs: temperature-sensitive shipments that arrive warm have a failure rate above 60%. Refrigeration at 2–8°C is non-negotiable after reconstitution. Storing TB-500 in a standard household refrigerator works if you keep the vial toward the back of the middle shelf. Not in the door (temperature fluctuates every time you open it) and not in the crisper drawer (often too cold, risking freeze damage). Freezing reconstituted TB-500 causes ice crystal formation that physically ruptures the peptide structure. If you accidentally freeze a vial, discard it. Thawing won't restore bioactivity. The 28-day window after reconstitution isn't arbitrary. It's based on bacteriostatic water's preservati…
02

Question drills

Open a question for its connected answer.

01What If I Use TB-500 Without Addressing DHT—Will It Work?+

No—TB-500 doesn't inhibit 5-alpha reductase or block androgen receptors. If your hair loss is driven by DHT (as it is in 95% of male pattern baldness and most female pattern hair loss), thymosin beta-4 won't stop the underlying miniaturisation process. You'll create a better microenvironment for follicles while the hormonal cascade continues shrinking them. The result: minimal to no visible improvement. Effective protocols combine TB-500 with a DHT-blocking agent (finasteride, dutasteride, topical spironolactone, or saw palmetto) plus a growth stimulant like minoxidil.

SOURCE / realpeptides.co ↗
02What If I Use TB-500 Without Following My Physical Therapy Protocol?+

TB-500 enhances collagen deposition but does not restore proprioception, neuromuscular control, or quadriceps strength. All of which predict re-injury risk more reliably than graft tensile strength alone. A 2022 meta-analysis in Orthopedic Journal of Sports Medicine found that patients who achieved <90% limb symmetry index on hop testing at six months had 4.2× higher re-tear rates regardless of graft type. TB-500 cannot replace progressive loading, eccentric strengthening, or sport-specific agility training.

SOURCE / realpeptides.co ↗
03What If the Reconstituted Peptide Appears Cloudy or Contains Visible Particles?+

Discard it immediately. TB-500 should form a clear, colorless solution upon reconstitution. Cloudiness indicates protein aggregation or precipitation caused by improper pH, excessive agitation during mixing, or freeze-thaw cycles that disrupt tertiary structure. Aggregated peptides lose actin-binding affinity and may trigger immune responses. Never inject a cloudy solution regardless of cost. The peptide is no longer pharmacologically active.

SOURCE / realpeptides.co ↗
04What if TB-500 was administered intravenously instead of subcutaneously — would faster absorption improve tissue repair outcomes?+

Unlikely. IV administration produces higher Cmax but shorter duration above therapeutic threshold. A 5mg IV bolus reaches peak plasma concentration immediately (within 5 minutes), but the rapid spike triggers faster redistribution into tissues and accelerated renal clearance, dropping plasma levels below 100 ng/mL within 36–48 hours compared to 48–72 hours with subcutaneous dosing. The compressed pharmacokinetic window means IV dosing would require administration every 2–3 days to maintain therapeutic levels. More frequent than the twice-weekly schedule sufficient for subcutaneous. Subcutaneous injection's slower absorption phase functions as an in vivo depot, releasing peptide gradually and extending the therapeutic window without requiring more frequent dosing.

SOURCE / realpeptides.co ↗
05What if I'm offered stem cell therapy for knee osteoarthritis — should I expect cartilage regrowth?+

Don't. The 2023 Osteoarthritis and Cartilage meta-analysis found pain and function improvements but no consistent cartilage thickness increases on MRI. Most therapeutic benefit likely comes from the anti-inflammatory cytokines released by injected cells before they're cleared, not from engraftment and differentiation into new cartilage. If the clinic promises 'cartilage regeneration,' ask for their imaging data showing pre- and post-treatment cartilage thickness in prior patients. Few can provide it.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Neurological Research

Studies in traumatic brain injury models demonstrate neuroprotective effects with administration of this peptide, including improved neurological functional recovery in stroke models. Research identified concentration-dependent effects, with optimal ranges significantly enhancing outcomes compared to controls. These findings position this class of repair peptides as candidates for neuroregenerative research applications alongside established neuroprotective compounds.

RESEARCH

The Evidence Gap Between Preclinical Data and Human Hair Loss Treatment

No FDA-approved indication for TB-500 exists for any condition. It remains a research peptide legally sold only for laboratory use under the Federal Food, Drug, and Cosmetic Act. Compounded TB-500 is available through veterinary compounding pharmacies and research supply vendors, but it is not evaluated by the FDA for purity, sterility, or clinical efficacy in humans. The absence of Phase II or Phase III clinical trials means dosing protocols, safety profiles, and comparative efficacy against minoxidil or finasteride are unknown. Anecdotal reports from bodybuilding and peptide-user communities describe TB-500 administered at 2–5mg subcutaneously twice weekly for injury recovery, with some users noting increased hair density on the scalp after 8–12 weeks. These reports lack photographic documentation, blinded assessment, or control for concurrent treatments (minoxidil, dermarolling, finasteride). Placebo response rates in hair-loss trials run 20–40%, so subjective improvement without objective measurement is uninformative. The peptide's half-life is approximately 10 days, meaning weekly dosing could maintain therapeutic plasma levels, but no pharmacokinetic study has established the relationship between systemic TB-500 concentration and follicular tissue levels. The cost-benefit calculation is unfavourable without clinical data. A 12-week TB-500 protocol at 5mg twice weekly costs approximately $600–$900 depending on the supplier, compared to $15–$30/month for generic finasteride or $40–$60/month for minoxidil. Both with decades of clinical validation. TB-500's mechanism overlaps partially with minoxidil (vascular effects) but doesn't address DHT, the primary driver of androgenetic alopecia. Combining TB-500 with a 5-alpha-reductase inhibitor is theoretically rational but untested. Without human trial data, you're paying research-peptide prices for veterinary-quality evidence. FDA Approval for Hair Loss No. Research peptide only Yes. 2% and 5% topical formulations approved 1988–1997 Yes. 1mg oral approved 1997 for male pattern baldness Yes. 0.5mg oral approved 2001 in some countries for benign prostatic hyperplasia, used off-label for alopecia TB-500 has biological plausibility but zero regulatory approval or clinical trial validation for alopecia. Minoxidil and finasteride remain evidence-based first-line treatments Mechanism of Action Beta-actin modulation, angiogenesis, anti-inflammatory signalling in wound repair Potassium channel opener, vasodilation, VEGF upregulation, anagen prolongation 5-alpha-reductase type II inhibition, reduces scalp DHT by ~70% Dual 5-alpha-reductase inhibition (types I and II), reduces scalp DHT by ~90% TB-500 doesn't address DHT. The primary pathogenic mechanism in androgenetic alopecia. Limiting its standalone efficacy compared to androgen-targeted therapies Clinical Trial Evidence Veterinary case studies, in-vitro follicle culture data, no human RCTs for alopecia Multiple Phase III RCTs showing 30–40% responder rate at 48 weeks Phase III trials demonstrating stabilisation in 80–90% and regrowth in 60–65% at 24 months Phase III trials showing superior DHT suppression and modest efficacy gains over finasteride Minoxidil and finasteride data span 30+ years with consistent reproducibility. TB-500 has zero comparable human evidence Dosing and Administration 2–5mg subcutaneous injection 1–2x weekly (extrapolated from veterinary protocols, not validated for humans) 1mL topical solution applied twice daily to dry scalp 1mg oral tablet once daily 0.5mg oral once daily or 2.5mg once weekly in some protocols TB-500 requires injection skill, sterile technique, and sourcing from unregulated suppliers. Minoxidil and finasteride are pharmacy-grade with standardised dosing Cost per Month $200–$300 depending on supplier and dosing frequency $15–$30 for generic, $40–$60 for brand $10–$25 for generic, $70–$90 for brand $30–$80 depending on formulation and source TB-500 costs 10–20× more than finasteride without superior or even equivalent evidence. Economically unjustifiable as monotherapy Side Effect Profile Injection-site reactions, unknown systemic effects in long-term human use, no formal safety data Scalp irritation, contact dermatitis, unwanted facial hair growth in ~5% of users, rare cardiovascular concerns Sexual side effects in 2–5%, reversible upon cessation in most cases, rare persistent effects documented Similar to finasteride but slightly higher incidence due to more complete DHT suppression TB-500's safety in chronic human use is uncharacterised. Finasteride's side effect profile is extensively mapped and manageable Bottom Line Biological mechanisms suggest potential but remain speculative without human trials. Not recommended as monotherapy when evidence-based alternatives exist First-line treatment with decades of data, modest efficacy, topical administration avoids systemic androgen effects Gold standard for androgenetic alopecia with robust long-term data and androgen-targeted mechanism Marginally more effective than finasteride due to dual enzyme inhibition but with slightly higher side effect risk. Second-line option after finasteride trial Use TB-500 only as adjunctive therapy alongside proven treatments if you're willing to absorb cost and risk without clinical validation. Never as a replacement for finasteride or minoxidil

05

Product & matchup locker

Linked catalog and comparison files.